Tristan Farmer

354 posts

Tristan Farmer banner
Tristan Farmer

Tristan Farmer

@001TMF

AI for programmable biologics & protein design | Building biological intelligence | Longevity & personalised therapies | GitHub: 001TMF | UoE

Beigetreten Şubat 2026
58 Folgt249 Follower
Angehefteter Tweet
Tristan Farmer
Tristan Farmer@001TMF·
Apple keyboard has become really painful to use. Can’t pinpoint when this started but is terrible now.
English
0
0
0
41
Tristan Farmer
Tristan Farmer@001TMF·
The protein AI race is playing out very differently to the LLM race. A year ago, Chai and Latent were the frontier of antibody and binder design, and the frontier was closed. Within months, Protenix, ESM, and Boltz open-sourced the tools. Who will win?
English
1
0
3
319
Tristan Farmer
Tristan Farmer@001TMF·
Alphafold once represented open science then closed AlphaFold 3 for profit. Code and weights are non-commercial only, and the lone commercial path runs through Isomorphic.
English
0
0
2
147
Tristan Farmer retweetet
nabbo (bio/acc)
nabbo (bio/acc)@TensorTwerker·
looking up my favourite proteins in esm atlas
nabbo (bio/acc) tweet media
English
2
2
31
1.2K
Tristan Farmer
Tristan Farmer@001TMF·
Does AI make genuine hypotheses? It just feels like a dictionary culmination of human knowledge
English
0
0
0
24
Tristan Farmer retweetet
Zeming Lin
Zeming Lin@ebetica·
How to design your own PD-1 binder in 4 easy steps: 1. Download the tutorial notebook from the ESM team 2. Get a @modal API key to scale it up 3. Scaling it up, O($1000) will get you a 96 well plate of minibinders with >50% success rates on typical targets 4. Test it in the lab!
Zeming Lin tweet media
English
4
14
76
8K
Garry Tan
Garry Tan@garrytan·
GStack is now one of the Top 100 Github open source projects of all time #100 and still climbing
Garry Tan tweet media
English
64
17
567
40.4K
Tristan Farmer
Tristan Farmer@001TMF·
The funniest thing about VC is that they ask founders for prophecy, then benchmark it against consensus. That is not market leadership. That is sheep behaviour with a Patagonia vest.
English
0
2
3
259
Michael (Jin Sub) Lee
Michael (Jin Sub) Lee@mjslee0921·
@001TMF @alexrives Unfortunately we were unable to access Protenix-v2 weights from their official repository - we would love to add this baseline when it becomes openly available!
English
1
0
1
57
Alex Rives
Alex Rives@alexrives·
Today we're announcing ESMFold2, an open scientific engine to power prediction, design, and discovery across protein biology. The new model delivers state of the art performance on protein interactions, especially antibodies, a critical modality for therapeutics. We have designed and validated miniprotein binders and single chain antibodies across five therapeutic targets that are important in cancer and immunology. We are seeing very high success rates, and affinities at levels consistent with therapeutic activity. We’re also releasing an atlas of 6.8 billion proteins, and 1.1 billion predicted structures. ESMFold2 is built on a state of the art language model that has been trained on billions of protein sequences. A world model of protein biology emerges through language modeling. We’ve used the techniques of mechanistic interpretability developed to understand large language models to understand the concepts ESM uses to represent proteins. The model’s representation space has a compositional organization of features across scales, levels of complexity, and abstraction, that reflects and mirrors the understanding of protein biology developed through a century of empirical science. This understanding emerges without prior knowledge, just from language modeling of protein sequences. Language models are becoming a powerful substrate to understand and program biology. The design of protein interactions is one of the most fundamental problems in biophysics, and has critical implications for the discovery of new medicines. A simple gradient based search with the model was able to discover high-affinity protein binders. I'm excited by the potential this has to accelerate basic science and the understanding of proteins. And especially for the new avenues it opens up for therapeutic design and medicine.
GIF
English
74
445
1.6K
587.3K
Anti Fund
Anti Fund@Antifund·
@001TMF That’s the right distinction. The company is not the model. It’s the closed loop from target to validated candidate. If AI removes the human bottleneck in design and validation, the product is workflow compression, not AI branding.
English
1
0
1
45
Anti Fund
Anti Fund@Antifund·
The best founders are not building AI-first companies. They are building companies that happen to use AI to make a previously impossible workflow real.
English
15
2
76
9.2K
Tristan Farmer
Tristan Farmer@001TMF·
Odd to not include protenix-v2 arguably the SOTA model for antibodies especially
Tristan Farmer tweet media
English
0
0
1
71
Tristan Farmer
Tristan Farmer@001TMF·
Very interesting.
Alex Rives@alexrives

Today we're announcing ESMFold2, an open scientific engine to power prediction, design, and discovery across protein biology. The new model delivers state of the art performance on protein interactions, especially antibodies, a critical modality for therapeutics. We have designed and validated miniprotein binders and single chain antibodies across five therapeutic targets that are important in cancer and immunology. We are seeing very high success rates, and affinities at levels consistent with therapeutic activity. We’re also releasing an atlas of 6.8 billion proteins, and 1.1 billion predicted structures. ESMFold2 is built on a state of the art language model that has been trained on billions of protein sequences. A world model of protein biology emerges through language modeling. We’ve used the techniques of mechanistic interpretability developed to understand large language models to understand the concepts ESM uses to represent proteins. The model’s representation space has a compositional organization of features across scales, levels of complexity, and abstraction, that reflects and mirrors the understanding of protein biology developed through a century of empirical science. This understanding emerges without prior knowledge, just from language modeling of protein sequences. Language models are becoming a powerful substrate to understand and program biology. The design of protein interactions is one of the most fundamental problems in biophysics, and has critical implications for the discovery of new medicines. A simple gradient based search with the model was able to discover high-affinity protein binders. I'm excited by the potential this has to accelerate basic science and the understanding of proteins. And especially for the new avenues it opens up for therapeutic design and medicine.

English
1
0
0
280